Our finding that TFE3 further accumulates in the nucleus of cancer cells lacking NMT1, LAMTOR1, or in cells treated with NMTi is consistent with both the inhibition of mTORC1 activity by NMTi, and the autophagy blockade provoked by the lack of degradative lysosomal activity. The gene discussed is LAMTOR1; the disease is cancer.